PATRICIA HEAD: Open Payments
NPI 1205822509 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,947 in 74 payments from 19 companies in 2025. Trend: 2023 $1,698 · 2024 $1,177 · 2025 $1,947
Food & beverage: $1,882Education: $65
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $427 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $383 |
| AstraZeneca Pharmaceuticals LP | 11 | $304 |
| ABBVIE INC. | 13 | $186 |
| Exact Sciences Corporation | 7 | $127 |
| Amgen Inc. | 4 | $63 |
| Abbott Laboratories | 3 | $62 |
| PFIZER INC. | 3 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $49 |
Products named: CAPLYTA, Ozempic, AIRSUPRA, Wegovy, Cologuard Collection Kit, QULIPTA, JARDIANCE, BREZTRI.
Industry payments across SC — which companies pay providers there.
